CTOs on the Move

MacuLogix

www.maculogix.com

 
MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.maculogix.com
  • 1801 Oberlin Road Suite 301
    Middletown, PA USA 17057
  • Phone: 717.914.4067

Executives

Name Title Contact Details

Funding

MacuLogix raised $10M on 07/18/2018
MacuLogix raised $38.7M on 03/04/2019

Similar Companies

Del Mar Medical

Del Mar Medical is a Mount Juliet, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cytrellis

Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life for our patients. Cytrellis` first product, the ellacor® System with Micro-Coring™ Technology, is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. Ellacor provides aesthetic practitioners with an unprecedented ability to improve age-related changes in skin and to help restore youthful beauty.

Archer OpTx Inc

Archer OpTx Inc is a Rowlett, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.

Premier Hospital Supply

Premier Hospital Supply is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.